ANTI-BCMA ANTIKÖRPER

Patent europeic · EP2406284 · En vigur

Inscripziun en il register

Numer da publicaziun
EP2406284
Numer da la dumonda
EP10708865
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
10-03-2010
Publitgà
18-01-2012
Concedì
27-07-2016
La protecziun finescha il pli tard
09-03-2030
Proxima taxa annuala scadenta
31-03-2027
Classas IPC
C07K 16/28 (2006.01)
A61K 39/395 (2006.01)
Prioritad
US 158942 P 10.03.2009
US 162924 P 24.03.2009
Dumonda PCT
PCT/US2010/026825 10.03.2010
Publicaziun PCT
WO2010/104949 16.09.2010
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-04-2026

    Midada

    Published in Swissreg on 01.04.2026

  2. 01-04-2025

    Midada

    Published in Swissreg on 01.04.2025

  3. 01-04-2024

    Midada

    Published in Swissreg on 01.04.2024

  4. 01-04-2023

    Midada

    Published in Swissreg on 01.04.2023

  5. 27-07-2016

    Concedì

    Published in Swissreg on 27.07.2016

Partidas

Possessur

Biogen MA Inc.

250 Binney Street, Cambridge, MA 02142, US

Inventur

KALLED, Susan, L.

Concord MA 01742, US

HSU, Yen-Ming

Lexington MA 02420, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.